The Journal of Pediatrics
Volume 154, Issue 4 , Pages 475-476 , April 2009

Stop the PPI Express: They Don't Keep Babies Quiet!

  • Philip E. Putnam, MD, FAAP

      Affiliations

    • Corresponding Author InformationReprint requests: Philip E. Putnam, MD, FAAP, Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, ML 2010, Cincinnati, OH 45229

References 

  1. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154:514–520
  2. Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr. 2003;143:147–148
  3. Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45:421–427
  4. Loots CM, Benninga MA, Davidson GP, Omari TI. Addition of pH-impedance monitoring to standard pH monitoring increases the yield of symptom association analysis in infants and children with gastroesophageal reflux. J Pediatr. 2009;154:248–252
  5. Orenstein SR, McGowan JD. Efficacy of conservative therapy as taught in the primary care setting for symptoms suggesting infant gastroesophageal reflux. J Pediatr. 2008;152:310–314

PII: S0022-3476(08)01044-5

doi: 10.1016/j.jpeds.2008.11.037

The Journal of Pediatrics
Volume 154, Issue 4 , Pages 475-476 , April 2009

Article Tools